Operating Expenses (Annual)

Operating Expenses: The sum of all operating expenses for the given industry.

Surgery Partners, Inc. (SGRY) had Operating Expenses of $2.92B for the most recently reported fiscal year, ending 2025-12-31.

Quarterly Annual

Figures for fiscal year ending 2025-12-31

Income Statement Financials
Revenue	$3.31B
Net Income	$-77.90M
Cost of Goods Sold	$2.54B
Gross Profit	$765.00M
Operating Expenses	$2.92B
Operating Income	$389.50M
Non-Operating Income/Expense	$-272.60M
Pre-Tax Income	$116.90M
Normalized Pre-Tax Income	$116.90M
Income after Taxes	$98.90M
Income from Continuous Operations	$98.90M
Consolidated Net Income/Loss	$98.90M
Normalized Income after Taxes	$98.90M
EBIT	$412.40M
EBITDA	$588.40M
Weighted-Average Shares Outstanding (Basic)	127.21M
Weighted-Average Shares Outstanding (Diluted)	127.21M
Earnings per Share (EPS) (Basic)	$-0.61
Earnings per Share (EPS) (Diluted)	$-0.61
Balance Sheet Financials
Current Assets	$1.15B
Property, Plant, and Equipment	$1.15B
Long-Term Assets	$6.97B
Total Assets	$8.12B
Current Liabilities	$615.50M
Long-Term Debt	$3.60B
Long-Term Liabilities	$4.37B
Total Liabilities	$4.99B
Common Equity	$3.13B
Tangible Shareholders Equity	$-2.10B
Shareholders Equity	$3.13B
Common Shares Outstanding	129.32M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$274.30M
Cash Flow from Investing Activities	$-246.60M
Cash Flow from Financial Activities	$-57.30M
Beginning Cash	$269.50M
End Cash	$239.90M
Increase/Decrease in Cash	$-29.60M
Stock-Based Compensation	$14.80M
Common Stock Dividends Paid	$-226.00M
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	1.87
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.54
Debt to Equity Ratio	1.18
Gross Margin	23.12%
Operating Margin	11.77%
EBIT Margin	12.46%
EBITDA Margin	17.78%
Pre-Tax Profit Margin	3.53%
Profit Margin	-2.35%
Free Cash Flow	$242.10M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.41
Inventory Turnover	26.33
Receiveable Turnover	5.49
Days Sales in Receivables	66.43
Return on Equity	3.16%
Return on Tangible Equity	-4.70%
Return on Assets	1.22%
Return on Investments	1.47%
Book Value Per Share	$24.21
Free Cash Flow per Share	$1.90
Operating Cash Flow per Share	$2.16

Data from Zacks Investment Research, Inc.